Back to search

Article

Plasma neutralization properties of the SARS-CoV-2 Omicron variant

2021-12-13

Abstract excerpt

<h4>BACKGROUND</h4> The Omicron SARS-CoV-2 variant has spread internationally and is responsible for rapidly increasing case numbers. The emergence of divergent variants in the context of a heterogeneous and evolving neutralizing antibody response in host populations might compromise protection afforded by vaccines or prior infection. <h4>METHODS</h4> We measured neutralizing antibody titers in 169 longitudinall...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a7da6e1d-1613-52c6-a9b0-9966d53419de
DOI
10.1101/2021.12.12.21267646
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Plasma neutralization properties of the SARS-CoV-2 Omicron variantDOI 10.1101/2021.12.12.21267646
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSemantic proximity
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variantSemantic proximity
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variantSemantic proximity
Neutralizing antibodies to SARS-CoV-2 Omicron variant after 3 <sup>rd</sup> mRNA vaccination in health care workers and elderly subjects and response to a single dose in previously infected adultsSemantic proximity
mRNA-Based COVID-19 Vaccine Boosters Induce Neutralizing Immunity Against SARS-CoV-2 Omicron VariantSemantic proximity
Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic AntibodiesSemantic proximity
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccinesSemantic proximity
SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernSemantic proximity
SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernSemantic proximity
The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemicSemantic proximity
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantSemantic proximity
SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3<sup>rd</sup> mRNA Vaccine DoseSemantic proximity
Select a neighboring publication to make it the new centre.